BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20065912)

  • 1. Low-dose azathioprine effectively suppresses clinical and immunological manifestations of generalized myasthenia.
    Finsterer J; Frank M; Krexner E
    South Med J; 2010 Feb; 103(2):182-4. PubMed ID: 20065912
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of malignancy in myasthenia gravis patients exposed to azathioprine therapy for a median period of 3 years.
    Rawoot A; Little F; Heckmann JM
    S Afr Med J; 2006 Dec; 96(12):1249-51. PubMed ID: 17252153
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myasthenia gravis. Opportunistic cytomegalovirus infection after long-term azathioprine therapy].
    Eisensehr I; Büttner U; Witt TN; von Appen K; Spuler S
    Nervenarzt; 1999 Oct; 70(10):924-6. PubMed ID: 10554786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis.
    Bromberg MB; Wald JJ; Forshew DA; Feldman EL; Albers JW
    J Neurol Sci; 1997 Sep; 150(1):59-62. PubMed ID: 9260858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis.
    Cosi V; Lombardi M; Erbetta A; Piccolo G
    Acta Neurol (Napoli); 1993 Apr; 15(2):123-31. PubMed ID: 8328322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term, low-dose immunosuppression for myasthenia does not affect collateral, asymptomatic sclerosing cholangitis.
    Finsterer J; Höflich S
    Arq Neuropsiquiatr; 2012 Feb; 70(2):158-9. PubMed ID: 22311226
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of primary central nervous system lymphoma with long-term azathioprine therapy for myasthenia gravis?
    Herrlinger U; Weller M; Dichgans J; Melms A
    Ann Neurol; 2000 May; 47(5):682-3. PubMed ID: 10805346
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
    Palace J; Newsom-Davis J; Lecky B
    Neurology; 1998 Jun; 50(6):1778-83. PubMed ID: 9633727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypersensitivity to azathioprine can simulate an aggravation of myasthenia].
    Chevrel G; Moreau T; Vial T; Payen C; Confavreux C
    Therapie; 1998; 53(1):77-8. PubMed ID: 9773103
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppressive drugs in treatment of myasthenia gravis.
    Rowland LP
    Ann N Y Acad Sci; 1971 Sep; 183():351-7. PubMed ID: 5287832
    [No Abstract]   [Full Text] [Related]  

  • 11. Azathioprine experience in severe, generalized, recalcitrant myasthenia gravis.
    Kornfeld P; Ambinder EP; Matta R; Bender A; Papatestas AE; Gross H; Genkins G
    Mt Sinai J Med; 1985 May; 52(5):347-52. PubMed ID: 3874354
    [No Abstract]   [Full Text] [Related]  

  • 12. [Delayed development of multiple supernumerary teeth in a patient with juvenile myasthenia gravis treated with azathioprine].
    Varela M; García-Camba P; Gutiérrez Mosquera B; García Rosas S; Lorda I
    An Pediatr (Barc); 2014 Sep; 81(3):200-1. PubMed ID: 24315416
    [No Abstract]   [Full Text] [Related]  

  • 13. Sweet syndrome as a manifestation of azathioprine hypersensitivity.
    El-Azhary RA; Brunner KL; Gibson LE
    Mayo Clin Proc; 2008 Sep; 83(9):1026-30. PubMed ID: 18775203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of myasthenia gravis during pregnancy.
    Bansal R; Goyal MK; Modi M
    Indian J Pharmacol; 2018; 50(6):302-308. PubMed ID: 30783322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Eruptive melanocytic nevi during azathioprine therapy in myasthenia gravis].
    Braun SA; Helbig D; Frank J; Hanneken S
    Hautarzt; 2012 Oct; 63(10):756-9. PubMed ID: 23008007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary CNS lymphoma in myasthenic on long-term azathioprine.
    Finelli PF
    J Neurooncol; 2005 Aug; 74(1):91-2. PubMed ID: 16078114
    [No Abstract]   [Full Text] [Related]  

  • 17. Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis.
    Hohlfeld R; Michels M; Heininger K; Besinger U; Toyka KV
    Neurology; 1988 Feb; 38(2):258-61. PubMed ID: 3340289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myasthenic crisis caused by azathioprine-induced fever].
    Tumani H; George A; Nau R
    Nervenarzt; 1997 Apr; 68(4):336-8. PubMed ID: 9273463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophilic dermatosis caused by azathioprine hypersensitivity.
    Hurtado-Garcia R; Escribano-Stablé JC; Pascual Jc; Devesa P; Matarredona J; Hurtado-Garcia R
    Int J Dermatol; 2012 Dec; 51(12):1522-5. PubMed ID: 22471306
    [No Abstract]   [Full Text] [Related]  

  • 20. [A post-thymomectomy case of myasthenia gravis which developed nephrotic syndrome with membranous nephropathy during azathioprine administration].
    Konishi T; Miki S; Yoshida A; Tei M
    Rinsho Shinkeigaku; 1996 Jul; 36(7):864-8. PubMed ID: 8952354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.